Ensuring Proper COVID-19 Vaccine Storage Temperature Monitoring

Primex OneVue will consistently and accurately monitor the temperature of your storage unit, ensuring your COVID-19 vaccines retain their efficacy

Pharmaceutical companies like Johnson & Johnson, Pfizer, and Moderna are leading the charge for developing safe and effective COVID-19 vaccines. While it’s still unknown exactly when these vaccines will be ready and approved by the Food and Drug Administration, certain trials have entered later phases, and researchers are hopeful to provide vaccinations to vulnerable populations before the end of 2020. Then, as additional vaccines are created and approved, more widespread distribution is planned for next year.

Even with a potential higher supply, the distribution and subsequent storage of COVID-19 vaccines could pose a challenge for some health care institutions. Recently, reports have stated some vaccines may need to be transported and stored at exceptionally cold temperatures, some as low as minus 94 F (minus 70 C), to remain effective. However, despite these extreme temperatures, a storage freezer equipped with Primex OneVue technology can provide you peace of mind. It continuously and reliably monitors internal temperature and provides automated alerts if temperatures fall below or rise above a specified range, allowing staff to remain informed and quickly troubleshoot, if necessary, to maintain supply.

The Latest in COVID-19 Vaccine Timing

As pressure mounts to quickly create an effective and approved vaccine, nine pharmaceutical companies released a joint statement on Sept. 8, 2020, pledging to uphold the integrity of scientific processes in vaccine creation. Among companies to collaborate on the pledge were giants of industry Pfizer, Johnson & Johnson, and AstraZeneca, who alongside others, stated that their companies will “continue to adhere to high scientific and ethical standards regarding the conduct of clinical trials and the rigor of manufacturing processes.”

While this statement doesn’t necessarily offer much insight into precisely when vaccines will be available, it should give hospitals, health systems, and clinics reassurance about the quality of an approved vaccine. It also can provide some additional time for healthcare facilities to proactively prepare their vaccine storage units for proper temperature monitoring.

Constant and Reliable COVID-19 Vaccine Storage Temperature Monitoring

Whereas some potential vaccines will reportedly require ultralow temperature storage, others, like those being developed by Sanofi and Novavax, reportedly will only require storage temperatures consistent with refrigeration, usually 35-45 F (2-8 C). No matter the required storage temperature, Primex OneVue Sense, part of the Primex OneVue System, can accurately monitor temperature inside storage units to protect the efficacy of these potentially lifesaving vaccines.

Automatic temperature monitoring is recorded by the Primex OneVue Temperature Sensor, which wirelessly connects and reports data to the cloud-based Primex OneVue Monitor platform. Available on any internet-connected device, the platform allows you to view current and past temperature data and run customizable reports when necessary for compliance checks. The Monitor platform also features threshold-based alerts, which can notify you to take action if temperatures fall below a certain point. This can be vital in protecting critical vaccines, especially when the initial supply may be low.

With manual reporting eliminated and potential vaccine inventory protected — thanks to Primex OneVue — health care staff will be able to focus more on the treatment of patients rather than accurate vaccine storage temperatures.

If you are concerned about storing your facility’s COVID-19 vaccines at the proper temperature, or if you are in need of new or upgraded temperature monitoring devices, Primex can help. Contact us today for a free consultation.